Dr. Ramesh Batra is a Tenured Professor of Surgery at the University of Arizona, where he serves as Division Chief and Director of Abdominal Transplantation at the Banner University Medical Center. A devoted surgeon and thought leader, he is advancing the future of transplantation by integrating artificial intelligence and deep machine learning with the art and science of surgery.

Dr. Thomas Reiberger is a Professor of Gastroenterology and Hepatology at the Medical University of Vienna and holds medical boards for Internal Medicine, Gastroenterology/Hepatology and ICU. He leads the advanced chronic liver disease (ACLD) program at the Vienna General Hospital, including outpatient clinics for patients with liver cirrhosis, portal hypertension, and for pre-post liver transplantation care. As physician scientist he performs invasive transjugular procedures, endoscopic hepatobiliary interventions and engages in intensive care management of GI/Liver patients.

Jordan Sack is a transplant hepatologist at Mass General Brigham. His research focus is in Fontan associated liver disease, cirrhosis, and portal hypertension.

I'm Vik Meadows, PhD, a postdoctoral fellow at the University of Pittsburgh researching the role of bile duct integrity in hepatocyte reprogramming and gut-liver axis homeostasis under the mentorship of Dr. Satdarshan 'Paul' Monga.

Neil Henderson is an academic hepatologist and Chair of Tissue Repair and Regeneration at the University of Edinburgh. Neil's group leverages cutting-edge approaches including the rapidly evolving field of single cell and spatial genomics to develop precision therapies for patients with liver fibrosis.

Anand Mehta, D.Phil. is the Senior Associate Dean for Research and SmartState Endowed Chair in Proteomic Biomarkers and Professor, Department of Cell and Molecular Pharmacology at the Medical University of South Carolina. Dr. Mehta received his graduate degree in Biochemistry from the University of Oxford under the mentorship of Professor Raymond Dwek and Nobel Laureate Baruch Blumberg. As a student, he worked on the role of N-linked glycosylation in the assembly and secretion of hepatitis B virus. Currently, Dr.

I am a gastroenterologist and hepatologist interested in using genomic methods to better understand disease mechanisms, especially in MASLD, liver cirrhosis and HCC.

Dr. Tombazzi is an Assistant Professor of Medicine at Vanderbilt University Medical Center in the Divisions of Gastroenterology, Hepatology and Nutrition as well as Palliative Care Medicine. He completed medical school at University of Tennessee Health Science Center-Memphis, internal medicine residency at VUMC and subsequently completed Hospice and Palliative Medicine Fellowship, Gastroenterology, and Transplant Hepatology fellowships at VUMC.

Dr. Lisa Deng is the Director of Liver Clinic at the San Francisco VA Healthcare System and Assistant Clinical Professor of Medicine at University of California, San Francisco. Dr. Deng's academic mission is to improve outcomes for patients with advanced liver disease through integration of geriatric and palliative care principles into hepatology care. She completed medical school, Internal Medicine residency, Gastroenterology and Transplant Hepatology fellowships at the University of California, San Francisco.

Dr. Raeman is an Associate Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a core member of Pittsburgh Liver Research Center. Dr. Raeman earned his MS from Clemson University, PhD from the University of Georgia and completed his postdoctoral training at Emory University School of Medicine. Dr. Raeman specializes in delineating the cellular and molecular mechanisms of chronic liver diseases, specifically focusing on the role of gut-liver-immune axis in chronic liver disease progression. The current research in Dr.